Riskpilot← Back to searchSign inGet full accessSIMPRINCO ApS
APSActiveCVR 10101611Haraldstedvej 99Activities of holding companies · NACE 6421Est. 2003— employees
Revenue 2024
DKK -8K
-11% vs 2023
EBITDA margin
100.0%
+11% vs 2023
Equity ratio
99.6%
Financial strength
Net profit 2024
DKK 87K
+139% vs 2023
| Revenue | DKK -8K | -11% |
| EBITDA | DKK -8K | +11% |
| Net profit | DKK 87K | +139% |
| Total assets | DKK 9,5M | -5% |
| Equity | DKK 9,5M | -5% |
| Employees | — | — |
Legal name
SIMPRINCO ApS
CVR number
10101611
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
1. januar 2003
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes direktøren.
Company purpose
Selskabets formål er alene at erhverve aktier i Cutisan Laboratorium A/S (CVR nr. 76570612) og at eje og administrere disse.
Address
Haraldstedvej 99
Phone
+4561676479
Email
simprinco@dyrbakholst-christensen.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -9 | -10 | -11 | -49 | -23 | -49 | -16 | -27 | -21 | -14 | -9 | -9 | -8 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -9 | -10 | -11 | -49 | -23 | -49 | -16 | -27 | -21 | -14 | -9 | -9 | -8 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -9 | -10 | -11 | -49 | -23 | -49 | -16 | -27 | -21 | -14 | -9 | -9 | -8 |
| Net financials | 910 | 989 | 1.436 | 989 | 1.235 | 1.237 | 1.266 | 82 | -716 | -421 | -135 | -206 | 129 |
| Profit before tax | 902 | 979 | 1.424 | 940 | 1.212 | 1.188 | 1.250 | 54 | -737 | -435 | -144 | -215 | 121 |
| Tax | 14 | 8 | 6 | -4 | -3 | -12 | -10 | -6 | -0 | -0 | -0 | 6 | 35 |
| Net profit | 888 | 971 | 1.418 | 945 | 1.215 | 1.200 | 1.260 | 60 | -737 | -435 | -144 | -221 | 87 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9.529 | 10.326 | 11.177 | 11.889 | 14.139 | 13.639 | 12.993 | 12.055 | 11.185 | 10.635 | 10.377 | 10.040 | 9.537 |
| Equity | 9.380 | 10.051 | 11.169 | 11.814 | 12.729 | 13.629 | 12.964 | 12.025 | 11.177 | 10.629 | 10.370 | 10.031 | 9.496 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 149 | 275 | 8 | 75 | 1.410 | 10 | 29 | 30 | 8 | 6 | 6 | 9 | 41 |
| Total debt | 149 | 275 | 8 | 75 | 1.410 | 10 | 29 | 30 | 8 | 6 | 6 | 9 | 41 |
EBITDA margin
-800000.0%
This company
15.8%
Market median
-5063391% vs market
20122024
Equity ratio
99.6%
This company
38.2%
Market median
+161% vs market
20122024
Return on equity
0.9%
This company
18.4%
Market median
-95% vs market
20122024
Net profit margin
8661500.0%
This company
8.1%
Market median
+106931999% vs market
20122024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20122024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AH Chief Executive Officer | Chief Executive Officer | 2003 | — | — |
CM Audit | Audit | 2003 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2003 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2003 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SIMPRINCO ApS 
CUTISAN LABORATORIUM ApSBoard members of SIMPRINCO ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Annemette Heller | Chief Executive Officer | 0 companies |
| Carl Munch | Audit | 0 companies |
| Kim Madsen | Chairman | 0 companies |